The Drug Information and Monitoring System (DIMS) in the Netherlands: Implementation, results, and international comparison

Drug Testing and Analysis

Volumn 3, Issue 9, 2011, Pages 621-634

  Brunt, Tibor M ^a   Niesink, Raymond J M ^a  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

Author keywords

Amphetamine; Cocaine; Drug monitoring; Ecstasy; MDMA

Indexed keywords

DRUG PRODUCTS; PATIENT MONITORING;

AMPHETAMINE; COCAINE; DRUG MONITORING; DRUG TESTING; ECSTASY; ILLICIT DRUG; MDMA; MONITORING SYSTEM; NETHERLANDS; RESULT COMPARISON;

HEALTH HAZARDS;

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; 4 METHOXYAMPHETAMINE; 4 METHOXYMETHAMPHETAMINE; 4 METHYLAMPHETAMINE; 4' METHYLMETHCATHINONE; AMPHETAMINE; ATROPINE; BENZOCAINE; CAFFEINE; COCAINE; CREATINE; DEXTROMETHORPHAN; DILTIAZEM; DIPHENHYDRAMINE; EPHEDRINE; GAMMA BUTYROLACTONE; HYDROXYZINE; ILLICIT DRUG; KETAMINE; LEVAMISOLE; LIDOCAINE; LYSERGIDE; METHAMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; NICOTINAMIDE; PHENACETIN; PHENTERMINE; PROCAINE;

DRUG CONTROL; DRUG IDENTIFICATION; DRUG INFORMATION; DRUG MONITORING; DRUG PURITY; DRUG SURVEILLANCE PROGRAM; DRUG TRAFFIC; DRUG USE; FRANCE; GAS CHROMATOGRAPHY; GERMANY; HEALTH CARE POLICY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NETHERLANDS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TABLET; TANDEM MASS SPECTROMETRY; THIN LAYER CHROMATOGRAPHY; UNITED STATES;

EID: 80053383764     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.323     Document Type: Review

References (92)

1. C. Mensink, I. Spruit, Jaarboek Verslaving 1998: over gebruik en zorg Bohn Stafleu & Van Loghum, Houten, 1999, pp. 44.
2. M. De Kort, T. Cramer, J. Drug Issues 1999, 29, 473.
3. I. Spruit, J. Drug Issues 1999, 29, 653.
4. H. Parker, J. Aldridge, F. Measham, P. Haynes, Health Educ. Res. 1999, 14, 707.
5. T. Nabben, High Amsterdam ISBN: 9789036102001D, Rozenberg, Amsterdam, 2010.
6. F. T. Pijlman, J. Krul, R. J. Niesink, Uitgaan en Veiligheid ISBN: 9052534357, Trimbos-Instituut, Utrecht, 2003.
7. I. Spruit, Subst. Use Misuse 2001, 36, 23.
8. H. M. Goldschmidt, Clin. Chem. Lab. Med. 2004, 42, 868.
9. A. Benschop, M. Rabes, D. Korf, Pill testing-Ecstasy & prevention ISBN: 9051706855, Rozenberg, Amsterdam, 2002.
10. D. Korf, A. Benschop, T. Brunt, Pill testing in The Netherlands ISBN: 9051707304, Rozenberg, Amsterdam, 2003.
11. N. Vogels, T. M. Brunt, S. Rigter, P. van Dijk, H. Vervaeke, R. J. Niesink, Addiction 2009, 104, 2057.
12. F. T. Pijlman, S. M. Rigter, J. Hoek, H. M. Goldschmidt, R. J. Niesink, Addict. Biol. 2005, 10, 171.
13. T. M. Brunt, S. Rigter, J. Hoek, N. Vogels, P. van Dijk, R. J. Niesink, Addiction 2009, 104, 798.
14. T. M. Brunt, M. van Laar, R. J. Niesink, W. van den Brink, Drug Alcohol Depend. 2010, 111, 21.
15. UNODC. Available at: [10 July 2010].
16. J. Segen, Dictionary of Modern Medicine ISBN: 9780838515358, The McGraw-Hill Companies, New York, NY, 2002.
17. A. C. Parrott, Psychopharmacology 2004, 173, 234.
18. K. Konijn, E. Pennings, F. De Wolff, XTC: clinical and toxicological aspects ISBN: 9090106154, Laboratory of Toxicology, Leiden, 1997.
19. D. Nichols, J. Psychoactive Drugs 1986, 18, 305.
20. E. Gouzoulis-Mayfrank, J. Dauman, F. Tuchtenhagen, S. Pelz, S. Becker, H. J. Kunert, B. Fimm, H. Sass, J. Neurol. Neurosurg. Psychiatry 2000, 68, 719.
21. R. S. El-Mallakh, H. D. Abraham, Ann. Clin. Psychiatry 2007, 19, 45.
22. E. J. Jaehne, A. Salem, R. J. Irvine, Psychopharmacology 2007, 194, 41.
23. H. E. Felgate, P. D. Felgate, R. A. James, D. N. Sims, D. C. Vozzo, J. Anal. Toxicol. 1998, 22, 169.
24. J. C. Kraner, D. J. McCoy, M. A. Evans, L. E. Evans, B. J. Sweeney, J Anal. Toxicol. 2001, 25, 645.
25. F. Schifano, A. Oyefeso, J. Corkery, K. Cobain, R. Jambert-Gray, G. Martinotti, A. H. Ghodse, Hum. Psychopharmacol. 2003, 18, 519.
26. R. Dams, E. A. De Letter, K. A. Mortier, J. A. Cordonnier, W. E. Lambert, M. H. Piette, S. Van Calenbergh, A. P. De Leenheer, J Anal. Toxicol. 2003, 27, 318.
27. S. Refstad, Acta Anaesthesiol. Scand. 2003, 47, 1298.
28. N. Rasmussen, On Speed: The Many Lives of Amphetamine ISBN: 9780814776391, NYU Press, New York, 2009.
29. W. Buisman Handboek Verslaving, Houten: Bohn Stafleu & Van Loghum, 2000, 22.
30. M. W. Van Laar, A. A. N. Cruts, M. M. J. van Ooyen-Houben, R. F. Meijer, T. Brunt, The Netherlands Drug Situation 2009 ISBN: 9789052536682, Trimbos Institute, Utrecht, 2010.
31. T. Ter Bogt, One Two Three Four: Popmuziek, Jeugdcultuur en Stijl ISBN: 9051896808, Lemma, Utrecht, 1997.
32. J. Doekhie, T. Nabben, D. Korf, Trendwatch 2009 ISBN: 9051707932, Rozenberg Publishers, Amsterdam, 2009.
33. Asia and Pacific Amphetamine-Type Stimulants Information Centre (APAIC). Available at: [1 July 2010].
34. L. King, Forensic Chemistry of Substance Misuse ISBN: 9780854041787, RSC Publishing, Cambridge, UK, 2009.
35. E. Fry, J. Levy, Pharmacology and abuse of cocaine, amphetamines, ecstasy and related designer drugs: a comprehensive review of their mode of action, treatment of abuse and intoxication ISBN: 9789048124473, Springer, New York, 2009.
36. EMCDDA. Available at: [26 August 2010].
37. D. Braida, A. Zani, V. Capurro, G. Rossoni, S. Pegorini, E. Gori, M. Sala, J. Pharmacol. Sci. 2008, 107, 408.
38. F. Schifano, M. Leoni, G. Martinotti, S. Rawaf, F. Rovetto, Cyberpsychol. Behav. 2003, 405.
39. L. Henderson, W. Glass, LSD: Still with us after all these years ISBN: 0787943797, Jossey-Bass, San Francisco, CA, 1994.
40. Erowid. Available at: [20 July 2010].
41. I. Giraudon, P. Bello, Subst. Use Misuse. 2007, 42, 1567.
42. J. D. Ramsey, M. A. Butcher, M. F. Murphy, T. Lee, A. Johnston, D. W. Holt, B. M. J. 2001, 323, 603.
43. S. L. Kenyon, J. D. Ramsey, T. Lee, A. Johnston, D. W. Holt, Ther. Drug Monit. 2005, 27, 793.
44. EMCDDA. Available at: [12 August 2010].
45. H. Helmlin Available at: [2 August 2010].
46. E. E. Tanner-Smith, Drug Alcohol Depend. 2006, 83, 247.
47. Dancesafe. Available at: [23 August 2010].
48. A. Matthews, R. Bruno, J. Johnston, E. Black, L. Degenhardt, M. Dunn Drug Alcohol Depend. 2009, 100, 24.
49. L. Topp, C. Breen, S. Kaye, S. Darke, Drug Alcohol Depend. 2004, 73, 189.
50. J. C. Cole, M. Bailey, H. R. Sumnall, G. F. Wagstaff, L. A. King, Addiction 2002, 97, 1531.
51. K. W. Simonsen, E. Kaa, E. Nielsen, D. Rollmann, Forensic Sci. Int. 2003, 131, 162.
52. A. M. Camilleri, D. Caldicott, Forensic Sci. Int. 2005, 151, 53.
53. S. P. Sharma, B. C. Purkait, S. C. Lahiri, Forensic Sci. Int. 2005, 152, 235.
54. S. Teng, S. Wu, C. Liu, J. Li, C. Chien, Forensic Sci. Int. 2006, 161, 202.
55. UNODC. Available at: [5 August 2010].
56. EMCDDA. Available at: [5 August 2010].
57. EMCDDA. Available at:, National reports 2005-2009 [5 August 2010].
58. EMCDDA. Available at:, Statistical bulletins 2004-2009 [3 August 2010].
59. National Drug and Alcohol Research Centre. Available at: [1 July 2010].
60. United States Drug Enforcement Administration. Available at: 3 [1 August 2010].
61. United States Drug Enforcement Administration. Available at: [5 July 2010].
62. EMCDDA. Available at:, EWS final reports 2004-2009 [21 August 2010].
63. A. Ritter, Int. J. Drug Policy 2010, 21, 265.
64. N. Katz, L. Panas, M. L. Kim, A. D. Audet, A. Bilansky, J. Eadie, P. Kreiner, F. C. Paillard, C. Thomas, G. Carrow Pharmacoepidemiol. Drug Safety 2010, 19, 115.
65. A. R. Winstock, L. R. Mitcheson, P. Deluca, Z. Davey, O. Corazza, F. Schifano, Addiction 2010, 106, 154. [Epub ahead of print].
66. F. Measham, K. Moore, R. Newcombe, Z. Welch, Drug Alcohol Today 2010, 10, 14.
67. S. D. Brandt, H. R. Sumnal, F. Measham, J. Cole B. M. J. 2010, 341, c3564.
68. S. D. Brandt, H. R. Sumnall, F. Measham, J. Cole, Drug Test. Analysis 2010, DOI: 10.1002/dta.204 [Epub ahead of print].
69. T. M. Brunt, A. Poortman, R. J. Niesink, W. van den Brink, J. Psychopharmacol. 2010, DOI: 10.1177/0269881110378370 [Epub ahead of print].
70. BBC. Available at: [4 December 2009].
71. A. Chang, J. Osterloh, J. Thomas, Clin. Pharmacol. Ther. 2010, 88, 408.
72. N. Y. Zhu, D. F. Legatt, A. R. Turner, Ann. Intern. Med. 2009, 150, 287.
73. J. A. Buchanan, J. A. Vogel, A. M. Eberhardt, J. Med. Toxicol. 2011, 7, 83. [Epub ahead of print].
74. M. Bradford, B. Rosenberg, J. Moreno, G. Dumyati, Ann. Intern. Med. 2010, 152, 758.
75. K. Morris, Lancet 2010, 375, 1333.
76. EMCDDA. Available at: [23 February 2010].
77. EMCDDA. Available at:, Risk assessments [1 September 2010].
78. F. Schifano, P. Deluca, A. Baldacchino, T. Peltoniemi N. Scherbaum, M. Torrens, M. Farre, I. Flores, M. Rossi, D. Eastwood, C. Guionnet, S. Rawaf, L. Agosti, R. Brigada, A. Majava, H. Siemann, M. Leoni, A. Tomasin, F. Rovetto, A. H. Ghodse Prog. Neuropsychopharmacol Biol. Psychiatry 2006, 30, 640.
79. J. Mounteney, S. Haugland, Int. J. Drug Policy 2009, 20, 161.
80. S. Legleye, C. Ben Lakhdar, S. Spilka, Drug Alcohol Rev. 2008, 27, 466.
81. M. Huerta-Fontela, M. T. Galceran, F. Ventura, Anal Chem. 2007, 79, 3821.
82. B. Kasprzyk-Hordern, R. M. Dinsdale, A. J. Guwy, Environ. Pollut. 2009, 157, 1773.
83. A. L. van Nuijs, I. Tarcomnicu, L. Bervoets, R. Blust, P. G. Jorens, H. Neels, A. Covaci, Anal. Bioanal. Chem. 2009, 395, 819.
84. B. Shao, D. Chen, J. Zhang, Y. Wu, C. Sun, J. Chromatogr. A 2009, 1216, 8312.
85. E. Zuccato, C. Chiabrando, S. Castiglioni, R. Bagnati, R. Fanelli, Environ. Health Perspect. 2008, 116, 1027.
86. A. C. Chiaia, C. Banta-Green, J. Field, Environ. Sci. Technol. 2008, 42, 8841.
87. A. Gamma, L. Jerome, M. E. Liechti, H. R. Sumnall, Drug Alcohol Depend. 2005, 77, 185.
88. P. N. Murphy, M. Wareing, J. Fisk, J. Psychopharmacol. 2006, 20, 447.
89. C. J. Morgan, L. Muetzelfeldt, M. Muetzelfeldt, D. J. Nutt, H. V. Curran, J. Psychopharmacol. 2010, 24, 147.
90. R. S. Falck, R. G. Carlson, J. Wang, H. A. Siegal, Drug Alcohol Depend. 2004, 74, 45.
91. R. Allott, R. Paxton, R. Leonard, Health Educ. Res. 1999, 14, 491.
92. J. W. Toumbourou, T. Stockwell, C. Neighbors, G. A. Marlatt, J. Sturge, J. Rehm, Lancet 2007, 369, 1391.